Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.

2.

Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease

3.

Children with cancer tumors lacking DNA repair may benefit from olaparib combined with ceralasertib.

4.

Screening for prostate cancer: is it time to give up digital rectal examination?

5.

Bladder cancer link to explosive ordnance exposure among Army veteran bomb disposal officers


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot